Trial intelligence / Profile preview

Concurrent chemoradiation plus adjuvant chemotherapy vs pelvic radiation alone in high‑risk and advanced endometrial carcinoma

2007-004917-33Phase 3Unknown

Sponsor: Leiden University Medical Center
Start: Dec 2007
Modality: Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries: 1

Overview

Phase 3, randomised trial of cisplatin, carboplatin and paclitaxel in endometrial cancer (EC) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: 5-year actuarial overall survival. Status: unknown.

Drugs

cisplatincarboplatinpaclitaxel

Conditions

endometrial cancer (EC)

Beyond the preview

Go deeper on 2007-004917-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-004917-33.